%20and%20Batch%20Production%20Records%20(BPR).png)
Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The company outlines near-term and long-term emission reduction goals across i...
The partnership focuses on strengthening peptide API supply chains and supporti...
USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical ...
Company brings isolator technology to sterile injectable manufacturing in India...
Company secures final ANDA approval with eligibility for 180 days of CGT exclus...
Programme records participation across premier management institutes and announ...
Partnership aims to expand access to treatment options for Hutchinson-Gilford P...
The single-dose vial is bioequivalent to Hospira’s reference product and will ...
Company to distribute and promote the once-weekly injectable therapy following ...
Formycon will complete the development of FYB206, prepare and file the regulator...
The once-daily oral therapy is administered as a 14-day course. Clinical trials ...
Approval enables access to targeted therapy for adults and adolescents aged 12 ...
Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Ku...
Biocon Group Chairperson recognised in Mumbai ceremony for contributions to gl...
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lif...
Lupus nephritis classifications indicate the severity and type of kidney damage,...
